New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models

BACKGROUND: Strategies to increase nucleic acid vaccine immunogenicity are needed to move towards clinical applications in oncology. In this study, we designed a new generation of DNA vaccines, encoding an engineered vesicular stomatitis virus glycoprotein as a carrier of foreign T cell tumor epitop...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Alessandra, Bastiancich, Chiara, Bausart, Mathilde, Ligot, Sophie, Lambricht, Laure, Vanvarenberg, Kevin, Ucakar, Bernard, Gallez, Bernard, Préat, Véronique, Vandermeulen, Gaëlle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021892/
https://www.ncbi.nlm.nih.gov/pubmed/33795383
http://dx.doi.org/10.1136/jitc-2020-001243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021892/
https://www.ncbi.nlm.nih.gov/pubmed/33795383
http://dx.doi.org/10.1136/jitc-2020-001243

Ejemplares similares